<DOC>
	<DOCNO>NCT00006087</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure chest x-ray chest CT scan may effective early detection lung cancer . PURPOSE : Randomized clinical trial compare effectiveness chest CT scan give year chest x-ray give year detect lung cancer patient high-risk develop lung cancer .</brief_summary>
	<brief_title>Chest X-Ray Chest CT Scan Patients High Risk Developing Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy lung cancer risk assessment questionnaire combine spirometry test identify statistically significant number person high-risk behavior development lung cancer . II . Determine sensitivity screen technique identify population high risk development lung cancer . III . Determine number patient necessary screen order identify high-risk population eligible study . IV . Determine lead time bias CT scan versus chest x-rays patient . V. Determine efficacy spiral CT scan chest detect early lung cancer visible chest x-rays patient high risk lung cancer . VI . Compare annual spiral CT scan versus annual chest x-rays detecting lung cancer patient . VII . Compare survival fatality patient detection method . OUTLINE : Patients randomize one two screening arm . Arm I : Patients receive routine medical care , annual nursing assessment , annual chest x-ray . Any new abnormality identify evaluated standard acceptable medical intervention . Arm II : Patients receive routine medical care , annual nursing assessment , annual spiral CT scan chest . If abnormal mass great 10 mm diameter 5-10 mm diameter highly suspicious malignancy detect , chest x-ray tissue diagnosis obtain . If abnormal mass 10 mm less diameter , thin section high resolution image mass obtain . If image normal benign , annual spiral CT scan continue . If image indeterminate , repeat high resolution scan perform 3 month . If image unchanged 3 month , annual spiral CT scan continue . If mass large 3 month , chest x-ray tissue diagnosis perform . Screening continue 5 year absence disease detection . PROJECTED ACCRUAL : A minimum 1,000 patient ( 500 per screen arm ) accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients high risk development lung cancer define follow : At least 40 pack year smoke ( may stop smoke within past 10 year ) time study entry FEV1/FVC ratio le 70 % predict OR FEV1 le 80 % predict obtained 3 serial performance le 5 % difference Normal stable current chest xray PATIENT CHARACTERISTICS : Age : 40 70 Performance status : Not specify Life expectancy : At least 5 year Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Pulmonary : See Disease Characteristics Other : No comorbidity limit life span le 5 year No prior cancer except nonmelanomatous skin cancer carcinoma situ cervix Not pregnant Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
</DOC>